BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Dec 19, 2011
 |  BC Week In Review  |  Company News  |  Deals

Dako, Roche deal

Dako and Roche's Genentech Inc. unit will collaborate on U.S. regulatory submissions for Dako's HercepTest and HER2 FISH pharmDx as companion diagnostics for Genentech's pertuzumab in patients with advanced, HER2-positive breast cancer. Dako is responsible for the registration and...

Read the full 203 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >